Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis.
Wang A, Keita ÅV, Phan V, McKay CM, Schoultz I, Lee J, Murphy MP, Fernando M, Ronaghan N, Balce D, Yates R, Dicay M, Beck PL, MacNaughton WK, Söderholm JD, McKay DM.
Wang A, et al. Among authors: phan v.
Am J Pathol. 2014 Sep;184(9):2516-27. doi: 10.1016/j.ajpath.2014.05.019. Epub 2014 Jul 14.
Am J Pathol. 2014.
PMID: 25034594
Free PMC article.